Danyi Ao

机构：Sichuan University, State Key Laboratory of Biotherapy · ORCID：0000-0003-3426-2730

发表论文 20 篇 · 总被引 691 次 · h-index 9

代表论文

• The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants (2023 · MedComm · 被引 144)
• SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development (2022 · MedComm · 被引 132)
• Targeting DNA repair pathway in cancer: Mechanisms and clinical application (2021 · MedComm · 被引 128)
• CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer (2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 95)
• Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period (2023 · Signal Transduction and Targeted Therapy · 被引 54)
• The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies (2024 · MedComm · 被引 46)